Clinical trials in Ukraine have experienced intense disruption as a result of Russia’s invasion, but companies such as Oximio have managed to find ways to continue with operations. Credit: ProStockStudio via Shutterstock.

This content is password protected. To view it please enter your password below:

Related Company Profiles

View all